Cost-Effectiveness of Cotrimoxazole Prophylaxis Among Persons With HIV in Uganda

BACKGROUND:Daily prophylaxis with trimethoprim-sulfamethoxazole (cotrimoxazole) by persons with HIV reduces morbidity and mortality and is recommended by Joint United Nations Program on HIV/AIDS and World Health Organization (WHO), but there are limited published cost-effectiveness data for this int...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2007-03, Vol.44 (3), p.336-343
Hauptverfasser:	Pitter, Christian, Kahn, James G, Marseille, Elliot, Lule, John R, McFarland, Deborah A, Ekwaru, John Paul, Bunnell, Rebecca, Coutinho, Alex, Mermin, Jonathan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult AIDS-Related Opportunistic Infections - prevention & control AIDS/HIV Algorithms Anti-Infective Agents - therapeutic use Antibiotics Biological and medical sciences Chemoprevention - economics Child Clinical outcomes Cost-Benefit Analysis Costs Drug therapy Fundamental and applied biological sciences. Psychology HIV Human immunodeficiency virus Human viral diseases Humans Infectious diseases Medical sciences Medical screening Microbiology Miscellaneous Multivariate analysis Rural areas Rural Population Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use Uganda Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!